Whilst at the AD/PD™ conference, we had the pleasure of speaking with Patrik Brundin about his talk on novel therapeutic targets for Parkinson’s disease.
Detecting caffeine levels in the blood may help to diagnose Parkinson’s disease, especially in its early stages.
A study supported by the National Institute on Aging has reported for the first time an association between higher glucose levels, altered glucose metabolism in the brain and Alzheimer’s pathology and symptom severity.
A team of UK-based researchers has been awarded a major grant to investigate the relationship between alterations in the gut microbiota & neurodegenerative disorders.
Study also reveals differences in the metabolism of macular telangiectasia sufferers that could lead to onset of the disease.